Skip to main content
Erschienen in: Clinical Orthopaedics and Related Research® 11/2009

01.11.2009 | Original Article

Rheologic Behavior of Osteoarthritic Synovial Fluid after Addition of Hyaluronic Acid: A Pilot Study

verfasst von: Pierre Mathieu, MD, Thierry Conrozier, MD, Eric Vignon, MD, Yves Rozand, MD, Marguerite Rinaudo, PhD

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

Viscosupplementation is a symptomatic treatment of osteoarthritis (OA) intended to restore rheologic homeostasis of the synovial fluid by injecting hyaluronic acid intraarticularly. Despite the long history of this therapy, little is known about its mechanisms of action and differences between commercial preparations. We investigated the rheologic behavior of OA synovial fluid with time, when stored at 4°C, before and after the addition of two hyaluronic acid commercial preparations (linear and cross-linked). Thirteen OA synovial fluids were stored at 4°C and assayed using steric exclusion chromatography, which allows hyaluronic acid to be separated from the remaining pool of proteins and its molecular weight and concentration to be determined without any pretreatment and calibration. The synovial fluid rheology also was studied in vitro, before and after addition of two viscosupplements, over 6 weeks. The non-Newtonian behavior of synovial fluid throughout followup appears to be the result of loose interactions between proteins and hyaluronic acid. When mixed with the linear hyaluronic acid, synovial fluid becomes less non-Newtonian whereas the non-Newtonian behavior was reinforced when mixed with the cross-linked hyaluronic acid. The rheology was nearly unchanged for all synovial fluids over 6 weeks. Our preliminary trial shows it is possible to study synovial fluid, stored at 4°C, over a long time and suggests the enzymatic degradation of hyaluronic acid is negligible under these experimental conditions.
Literatur
1.
Zurück zum Zitat Adam N, Ghosh P. Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fluid. Inflamm Res. 2001;50:294–299.PubMedCrossRef Adam N, Ghosh P. Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fluid. Inflamm Res. 2001;50:294–299.PubMedCrossRef
2.
Zurück zum Zitat Adams ME, Lussier AJ, Peyron JG. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Saf. 2000;23:115–130.PubMedCrossRef Adams ME, Lussier AJ, Peyron JG. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Saf. 2000;23:115–130.PubMedCrossRef
3.
Zurück zum Zitat Al-Assaf S, Phillips GO, Deeble DJ, Parsons B, Starnes H, Von Sonntag C. The enhanced stability of the crosslinked hylan structure to hydroxyl (OH) radicals compared with the uncrosslinked hyaluronan. Radiat Phys Chem. 1995;46:207–217.CrossRef Al-Assaf S, Phillips GO, Deeble DJ, Parsons B, Starnes H, Von Sonntag C. The enhanced stability of the crosslinked hylan structure to hydroxyl (OH) radicals compared with the uncrosslinked hyaluronan. Radiat Phys Chem. 1995;46:207–217.CrossRef
4.
Zurück zum Zitat Bagga H, Burkhardt D, Sambrook P, March L. Long term effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol. 2006;33:946–950.PubMed Bagga H, Burkhardt D, Sambrook P, March L. Long term effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol. 2006;33:946–950.PubMed
5.
Zurück zum Zitat Balazs EA. Analgesic effect of elastoviscous hyaluronan solutions and the treatment of arthritic pain. Cells Tissues Organs. 2003;174:49–62.PubMedCrossRef Balazs EA. Analgesic effect of elastoviscous hyaluronan solutions and the treatment of arthritic pain. Cells Tissues Organs. 2003;174:49–62.PubMedCrossRef
6.
Zurück zum Zitat Balazs EA. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results. Surg Technol Inter. 2004;12:278–289. Balazs EA. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results. Surg Technol Inter. 2004;12:278–289.
7.
Zurück zum Zitat Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3–9.PubMed Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3–9.PubMed
8.
Zurück zum Zitat Balazs EA, Gibbs DA. The rheological properties and biological function of hyaluronic acid. In: Balazs EA, ed. Chemistry and Molecular Biology of the Intercellular Matrix. London, UK: Academic Press; 1970:1241–1254. Balazs EA, Gibbs DA. The rheological properties and biological function of hyaluronic acid. In: Balazs EA, ed. Chemistry and Molecular Biology of the Intercellular Matrix. London, UK: Academic Press; 1970:1241–1254.
9.
Zurück zum Zitat Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum. 1967;10:357–376.PubMedCrossRef Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum. 1967;10:357–376.PubMedCrossRef
10.
Zurück zum Zitat Band PA. Molecular strategies for the therapeutic utilization of hyaluronan. In: Kennedy JF, Phillips GO, Williams PA, Hascall VS, eds. Hyaluronan, Volume 2: Biomedical, Medical and Clinical Aspects. Cambridge, UK: Woodhead Publishing; 2002:427–440. Band PA. Molecular strategies for the therapeutic utilization of hyaluronan. In: Kennedy JF, Phillips GO, Williams PA, Hascall VS, eds. Hyaluronan, Volume 2: Biomedical, Medical and Clinical Aspects. Cambridge, UK: Woodhead Publishing; 2002:427–440.
11.
Zurück zum Zitat Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2005;2:CD005321.PubMed Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2005;2:CD005321.PubMed
12.
Zurück zum Zitat Berriaud N, Milas M, Rinaudo M. Rheological study on mixtures of different molecular weight hyaluronates. Int J Biol Macromol. 1994;16:137–142.PubMedCrossRef Berriaud N, Milas M, Rinaudo M. Rheological study on mixtures of different molecular weight hyaluronates. Int J Biol Macromol. 1994;16:137–142.PubMedCrossRef
13.
Zurück zum Zitat Camenish TD, McDonald JA. Hyaluronan: is bigger better? Am J Resp Cell Mol Biol. 2000;23:431–433. Camenish TD, McDonald JA. Hyaluronan: is bigger better? Am J Resp Cell Mol Biol. 2000;23:431–433.
14.
Zurück zum Zitat Dahl LB, Dahl IM, Engström-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985;44:817–822.PubMedCrossRef Dahl LB, Dahl IM, Engström-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985;44:817–822.PubMedCrossRef
15.
Zurück zum Zitat Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage. 2006;14:814–822.CrossRef Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage. 2006;14:814–822.CrossRef
16.
Zurück zum Zitat Felson DT. The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum. 1990;20(suppl 1):42–50.PubMedCrossRef Felson DT. The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum. 1990;20(suppl 1):42–50.PubMedCrossRef
17.
Zurück zum Zitat Fergusson J, Boyle JA, McSween NM, Jasani MK. Observations on the flow properties of the synovial fluid from patients with rheumatoid arthritis. Biorheology. 1968;5:119–131. Fergusson J, Boyle JA, McSween NM, Jasani MK. Observations on the flow properties of the synovial fluid from patients with rheumatoid arthritis. Biorheology. 1968;5:119–131.
18.
Zurück zum Zitat Fouissac E, Milas M, Rinaudo M. Shear-rate, concentration, molecular weight, and temperature viscosity dependences of hyaluronates, a wormlike polyelectrolyte. Macromolecules. 1993;26:6945–6951.CrossRef Fouissac E, Milas M, Rinaudo M. Shear-rate, concentration, molecular weight, and temperature viscosity dependences of hyaluronates, a wormlike polyelectrolyte. Macromolecules. 1993;26:6945–6951.CrossRef
19.
Zurück zum Zitat Fouissac E, Milas M, Rinaudo M, Borsali R. Influence of the ionic strength on the dimensions of sodium hyaluronate. Macromolecules. 1992;25:5613–5617.CrossRef Fouissac E, Milas M, Rinaudo M, Borsali R. Influence of the ionic strength on the dimensions of sodium hyaluronate. Macromolecules. 1992;25:5613–5617.CrossRef
20.
Zurück zum Zitat Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum. 2002;32:10–37.PubMedCrossRef Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum. 2002;32:10–37.PubMedCrossRef
21.
Zurück zum Zitat Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage. 2005;13:216–224.PubMedCrossRef Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage. 2005;13:216–224.PubMedCrossRef
22.
Zurück zum Zitat Gomez JE, Thurston GB. Comparisons of the oscillatory shear viscoelasticity and composition of pathological synovial fluids. Biorheology. 1993;30:409–427.PubMed Gomez JE, Thurston GB. Comparisons of the oscillatory shear viscoelasticity and composition of pathological synovial fluids. Biorheology. 1993;30:409–427.PubMed
23.
Zurück zum Zitat Gomis A, Pawlak M, Balazs EA, Schmidt RF, Belmonte C. Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis Rheum. 2004;50:314–326.PubMedCrossRef Gomis A, Pawlak M, Balazs EA, Schmidt RF, Belmonte C. Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis Rheum. 2004;50:314–326.PubMedCrossRef
24.
Zurück zum Zitat Greenberg DD, Stoker A, Kane S, Cockrell M, Cook JL. Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis. Osteoarthritis Cartilage. 1993;1:97–103.CrossRef Greenberg DD, Stoker A, Kane S, Cockrell M, Cook JL. Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis. Osteoarthritis Cartilage. 1993;1:97–103.CrossRef
25.
Zurück zum Zitat Jackson DW, Simon TM. Intra-articular distribution and residence time of Hylan A and B: a study in the goat knee. Osteoarthritis Cartilage. 2006;14:1248–1257.PubMedCrossRef Jackson DW, Simon TM. Intra-articular distribution and residence time of Hylan A and B: a study in the goat knee. Osteoarthritis Cartilage. 2006;14:1248–1257.PubMedCrossRef
26.
Zurück zum Zitat Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis. 1957;16:494–501.PubMedCrossRef Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis. 1957;16:494–501.PubMedCrossRef
27.
Zurück zum Zitat Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of the high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage. 2006;14:154–162.PubMedCrossRef Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of the high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage. 2006;14:154–162.PubMedCrossRef
28.
Zurück zum Zitat Kogan G, Soltes L, Stern R, Gemeiner P. Hyaluronic acid: a natural biopolymer with abroad range of biomedical and industrial applications. Biotechnol Lett. 2007;29:17–25.PubMedCrossRef Kogan G, Soltes L, Stern R, Gemeiner P. Hyaluronic acid: a natural biopolymer with abroad range of biomedical and industrial applications. Biotechnol Lett. 2007;29:17–25.PubMedCrossRef
29.
Zurück zum Zitat Kotevoglu N, Lyibozkurt PC, Hiz O, Toktas H, Kuran B. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int. 2006;26:325–330.PubMedCrossRef Kotevoglu N, Lyibozkurt PC, Hiz O, Toktas H, Kuran B. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int. 2006;26:325–330.PubMedCrossRef
30.
Zurück zum Zitat Kraus VB, Stabler TV, Kong SY, Varju G, McDaniel G. Measurement of synovial fluid volume using urea. Osteoarthritis Cartilage. 2007;15:1217–1220.PubMedCrossRef Kraus VB, Stabler TV, Kong SY, Varju G, McDaniel G. Measurement of synovial fluid volume using urea. Osteoarthritis Cartilage. 2007;15:1217–1220.PubMedCrossRef
31.
Zurück zum Zitat Lapcik L Jr, Lapcik L, de Smedt S, Demeester J, Chabrecek P. Hyaluronan: preparation, structure, properties and applications. Chem Rev. 1998;98:2663–2684.PubMedCrossRef Lapcik L Jr, Lapcik L, de Smedt S, Demeester J, Chabrecek P. Hyaluronan: preparation, structure, properties and applications. Chem Rev. 1998;98:2663–2684.PubMedCrossRef
32.
Zurück zum Zitat Lee HG, Cowman MK. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal Biochem. 1994;219:278–287.PubMedCrossRef Lee HG, Cowman MK. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal Biochem. 1994;219:278–287.PubMedCrossRef
33.
Zurück zum Zitat Lee S, Park D, Chmell S. Viscosupplementation with hylan G-F 20 (Synvisc): pain and mobility observations from 74 consecutive patients. J Knee Surg. 2004;17:73–77.PubMed Lee S, Park D, Chmell S. Viscosupplementation with hylan G-F 20 (Synvisc): pain and mobility observations from 74 consecutive patients. J Knee Surg. 2004;17:73–77.PubMed
34.
35.
Zurück zum Zitat Milas M, Rinaudo M. Characterization and properties of hyaluronic acid (hyaluronan). In: Dimitriu S, ed. Polysaccharides: Structural Diversity and Functional Versatility. New York, NY: Marcel Dekker; 2002:535–549. Milas M, Rinaudo M. Characterization and properties of hyaluronic acid (hyaluronan). In: Dimitriu S, ed. Polysaccharides: Structural Diversity and Functional Versatility. New York, NY: Marcel Dekker; 2002:535–549.
36.
Zurück zum Zitat Milas M, Rinaudo M, Roure I, Al-Assaf S, Phillips GO, Williams PA. Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution. Biopolymers. 2001;59:191–204.PubMedCrossRef Milas M, Rinaudo M, Roure I, Al-Assaf S, Phillips GO, Williams PA. Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution. Biopolymers. 2001;59:191–204.PubMedCrossRef
37.
Zurück zum Zitat Milas M, Rinaudo M, Roure I, Al-Assaf S, Phillips GO, Williams PA. Rheological behaviour of hyaluronan, healon and hylan in aqueous solution. In: Kennedy JF, Phillips GO, Williams PA, Hascall VC, eds. Hyaluronan, Volume 1: Chemical, Biochemical and Biological Aspects. Cambridge, UK: Woodhead Publishing; 2002:181–193. Milas M, Rinaudo M, Roure I, Al-Assaf S, Phillips GO, Williams PA. Rheological behaviour of hyaluronan, healon and hylan in aqueous solution. In: Kennedy JF, Phillips GO, Williams PA, Hascall VC, eds. Hyaluronan, Volume 1: Chemical, Biochemical and Biological Aspects. Cambridge, UK: Woodhead Publishing; 2002:181–193.
38.
Zurück zum Zitat Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Theor. 2003;5:54–57.CrossRef Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Theor. 2003;5:54–57.CrossRef
39.
Zurück zum Zitat Nuki G, Ferguson J. Studies on the nature and significance of macromolecular complexes in the rheology of synovial fluid from normal and diseased human joints. Rheol Acta. 1971;10:8–14.CrossRef Nuki G, Ferguson J. Studies on the nature and significance of macromolecular complexes in the rheology of synovial fluid from normal and diseased human joints. Rheol Acta. 1971;10:8–14.CrossRef
40.
Zurück zum Zitat Praest BM, Greiling H, Kock R. Assay of synovial fluid parameters: hyaluronan concentration as a potential marker for joint diseases. Clin Chim Acta. 1997;266:117–128.PubMedCrossRef Praest BM, Greiling H, Kock R. Assay of synovial fluid parameters: hyaluronan concentration as a potential marker for joint diseases. Clin Chim Acta. 1997;266:117–128.PubMedCrossRef
41.
Zurück zum Zitat Praest BM, Greiling H, Kock R. Effects of oxygen-derived free radicals on the molecular weight and the polydispersity of hyaluronan solutions. Carbohydr Res. 1997;303:153–157.CrossRef Praest BM, Greiling H, Kock R. Effects of oxygen-derived free radicals on the molecular weight and the polydispersity of hyaluronan solutions. Carbohydr Res. 1997;303:153–157.CrossRef
42.
Zurück zum Zitat Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage. 2002;10:506–517.PubMedCrossRef Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage. 2002;10:506–517.PubMedCrossRef
43.
Zurück zum Zitat Reichenbach S, Blank S, Rutjes AW, Shang A, King EA, Dieppe PA, Juni P, Trelle S. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum. 2007;57:1410–1418.PubMedCrossRef Reichenbach S, Blank S, Rutjes AW, Shang A, King EA, Dieppe PA, Juni P, Trelle S. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum. 2007;57:1410–1418.PubMedCrossRef
44.
Zurück zum Zitat Rinaudo M. Advances in characterisation of polysaccharides in aqueous solution and gel state. In: Dimitriu S, ed. Polysaccharides: Structural Diversity and Functional Versatility. Ed 2. New York, NY: Marcel Dekker; 2004:237–252. Rinaudo M. Advances in characterisation of polysaccharides in aqueous solution and gel state. In: Dimitriu S, ed. Polysaccharides: Structural Diversity and Functional Versatility. Ed 2. New York, NY: Marcel Dekker; 2004:237–252.
45.
Zurück zum Zitat Rinaudo M. Properties and degradation of selected polysaccharides. Corros Eng Sci Technol. 2007;42:324–334.CrossRef Rinaudo M. Properties and degradation of selected polysaccharides. Corros Eng Sci Technol. 2007;42:324–334.CrossRef
46.
Zurück zum Zitat Rinaudo M. Rheological investigation on hyaluronan-fibrinogen interaction. Int J Biol Macromol. 2008;43:444–450.PubMedCrossRef Rinaudo M. Rheological investigation on hyaluronan-fibrinogen interaction. Int J Biol Macromol. 2008;43:444–450.PubMedCrossRef
47.
Zurück zum Zitat Rinaudo M, Roure I, Milas M. Use of steric exclusion chromatography to characterize hyaluronan, a semi-rigid polysaccharide. Int J Polym Anal Charact. 1999;5:277–287.CrossRef Rinaudo M, Roure I, Milas M. Use of steric exclusion chromatography to characterize hyaluronan, a semi-rigid polysaccharide. Int J Polym Anal Charact. 1999;5:277–287.CrossRef
48.
Zurück zum Zitat Saari H, Konttinen YT. Determination of synovial fluid hyaluronate concentration and polymerisation by high performance liquid chromatography. Ann Rheum Dis. 1989;48:565–570.PubMedCrossRef Saari H, Konttinen YT. Determination of synovial fluid hyaluronate concentration and polymerisation by high performance liquid chromatography. Ann Rheum Dis. 1989;48:565–570.PubMedCrossRef
49.
Zurück zum Zitat Schiller J, Fuchs B, Arnhold J, Arnold K. Contribution of reactive oxygen species to cartilage degradation in rheumatic diseases: molecular pathways, diagnosis and potential therapeutic strategies. Curr Med Chem. 2003;10:2123–2145.PubMedCrossRef Schiller J, Fuchs B, Arnhold J, Arnold K. Contribution of reactive oxygen species to cartilage degradation in rheumatic diseases: molecular pathways, diagnosis and potential therapeutic strategies. Curr Med Chem. 2003;10:2123–2145.PubMedCrossRef
50.
Zurück zum Zitat Soltes L, Kogan G, Stankovska M, Mendichi R, Rychly J, Schiller J, Gemeiner P. Degradation of high-molar-mass hyaluronan and characterization of fragments. Biomacromolecules. 2007;8:2697–2705.PubMedCrossRef Soltes L, Kogan G, Stankovska M, Mendichi R, Rychly J, Schiller J, Gemeiner P. Degradation of high-molar-mass hyaluronan and characterization of fragments. Biomacromolecules. 2007;8:2697–2705.PubMedCrossRef
51.
Zurück zum Zitat Soltes L, Stankovska M, Kogan G, Mendichi R, Volpi N, Sasinkova V, Gemeiner P. Degradation of high-molar-mass hyaluronan by an oxidative system comprising ascorbate, Cu(II), and hydrogen peroxide: inhibitory action of antiinflammatory drugs Naproxen and acetylsalicylic acid. J Pharm Biomed Anal. 2007;44:1056–1063.PubMedCrossRef Soltes L, Stankovska M, Kogan G, Mendichi R, Volpi N, Sasinkova V, Gemeiner P. Degradation of high-molar-mass hyaluronan by an oxidative system comprising ascorbate, Cu(II), and hydrogen peroxide: inhibitory action of antiinflammatory drugs Naproxen and acetylsalicylic acid. J Pharm Biomed Anal. 2007;44:1056–1063.PubMedCrossRef
52.
Zurück zum Zitat Tamir E, Robinson D, Koren R, Agar G, Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol. 2001;19:265–270.PubMed Tamir E, Robinson D, Koren R, Agar G, Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol. 2001;19:265–270.PubMed
53.
Zurück zum Zitat Vendrely C, Valadie H, Bednarova L, Cardin L, Pasdeloup M, Cappadoro J, Bednar J, Rinaudo M, Jamin M. Assembly of the full-length recombinant mouse prion protein I: formation of soluble oligomers. Biochim Biophys Acta. 2005;1724:355–366.PubMed Vendrely C, Valadie H, Bednarova L, Cardin L, Pasdeloup M, Cappadoro J, Bednar J, Rinaudo M, Jamin M. Assembly of the full-length recombinant mouse prion protein I: formation of soluble oligomers. Biochim Biophys Acta. 2005;1724:355–366.PubMed
54.
Zurück zum Zitat Vitanzo PC, Sennett BJ. Hyaluronans: is clinical effectiveness dependent on molecular weight? Am J Orthop. 2006;35:421-428.PubMed Vitanzo PC, Sennett BJ. Hyaluronans: is clinical effectiveness dependent on molecular weight? Am J Orthop. 2006;35:421-428.PubMed
55.
Zurück zum Zitat Waddell DD, Marino AA. Chronic knee effusions in patients with advanced osteoarthritis: implications for functional outcome of viscosupplementation. J Knee Surg. 2007;20:181–184.PubMed Waddell DD, Marino AA. Chronic knee effusions in patients with advanced osteoarthritis: implications for functional outcome of viscosupplementation. J Knee Surg. 2007;20:181–184.PubMed
56.
Zurück zum Zitat Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage. 2006;14:1237–1247.PubMedCrossRef Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage. 2006;14:1237–1247.PubMedCrossRef
57.
Zurück zum Zitat Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol. 1986;119:219–234.PubMedCrossRef Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol. 1986;119:219–234.PubMedCrossRef
58.
Zurück zum Zitat Weiss C. Why viscoelasticity is important for the medical uses of hyaluronan and Hylans. In: Abatangelao G, Veigel PH, eds. New Frontiers in Medical Sciences: Redefining Hyaluronan. Amsterdam, The Netherlands: Elsevier Science BV; 2000:89–103. Weiss C. Why viscoelasticity is important for the medical uses of hyaluronan and Hylans. In: Abatangelao G, Veigel PH, eds. New Frontiers in Medical Sciences: Redefining Hyaluronan. Amsterdam, The Netherlands: Elsevier Science BV; 2000:89–103.
59.
Zurück zum Zitat Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G, Vetter G, Balazs E. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther. 1999;21:1549–1562.PubMedCrossRef Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G, Vetter G, Balazs E. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther. 1999;21:1549–1562.PubMedCrossRef
Metadaten
Titel
Rheologic Behavior of Osteoarthritic Synovial Fluid after Addition of Hyaluronic Acid: A Pilot Study
verfasst von
Pierre Mathieu, MD
Thierry Conrozier, MD
Eric Vignon, MD
Yves Rozand, MD
Marguerite Rinaudo, PhD
Publikationsdatum
01.11.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Orthopaedics and Related Research® / Ausgabe 11/2009
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-009-0867-x

Weitere Artikel der Ausgabe 11/2009

Clinical Orthopaedics and Related Research® 11/2009 Zur Ausgabe

Symposium: Selected Papers Presented at the 2008 Meeting of the Musculoskeletal Tumor Society

Joint Preservation after Extensive Curettage of Knee Giant Cell Tumors

Symposium: Selected Papers Presented at the 2008 Meeting of the Musculoskeletal Tumor Society

Compressive Osseointegration of Tibial Implants in Primary Cancer Reconstruction

Symposium: Selected Papers Presented at the 2008 Meeting of the Musculoskeletal Tumor Society

Megaprosthesis versus Condyle-sparing Intercalary Allograft: Distal Femoral Sarcoma

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.